AH
ESPR icon

Aviva Holdings’s Esperion Therapeutics ESPR Stock Holding History

Aviva Holdings’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-441,649
Closed -$17.7M – 6
2019
Q1 		$17.7M Sell
441,649
-23,000
-5% -$1.03M 3.89% 4
2018
Q4 		$21.4M Sell
464,649
-735,451
-61% -$35.4M 6.74% 4
2018
Q3 		$53.2M Hold
1,200,100
– – 14.21% 3
2018
Q2 		$47M Buy
1,200,100
+1,032,513
+616% +$52.2M 7.64% 4
2018
Q1 		$12.1M Sell
167,587
-121,513
-42% -$8.92M 4.92% 4
2017
Q4 		$14.5M Hold
289,100
– – 8.49% 4
2017
Q3 		$14.5M Sell
289,100
-51,000
-15% -$2.46M 7.53% 3
2017
Q2 		$15.7M Hold
340,100
– – 9.92% 2
2017
Q1 		$12M Buy
+340,100
New +$7.79M 5.6% 3

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return